Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In vitro result
A potential unifying feature that enhances susceptibility among those with each of these conditions is an elevation in systemic inflammation, which leads to a greater viral load with the potential for a cytokine storm and increased mortality 3
Impaired glucose tolerance and impaired fasting glucose
It is a human glucagon-like peptide-1 (GLP-1) receptor agonist and antidiabetic medication prescribed for weight management and type 2 diabetes
The promising results from the Phase III SOUL trial, which demonstrated a 14% reduction in MACE occurrence with Rybelsus, have further validated its role in cardiovascular disease prevention
Our structured patient care includes video consultations and ongoing monitoring to ensure your dosage is optimised for both safety and efficacy
